Amid worries that Chad Billingsley will miss the remainder of the season after leaving his August 24 start with an elbow injury the Dodgers right-hander got a platelet-rich plasma injection yesterday.
For now the team is calling Billingsley’s injury merely “inflammation,” but Ken Gurnick of MLB.com notes that “the PRP injection is generally used for tears in tendons and ligaments.”
Don Mattingly indicated to Gurnick that Billingsley will attempt to start a throwing program after receiving the injection and if it doesn’t go smoothly he’ll likely be shut down for the year.
Billingsley has had a very strong season, starting 25 games with a 3.55 ERA and 128/45 K/BB ratio in 150 innings, posting his best ERA since 2008 and his best K/BB ratio ever.
Bob Nightengale of USA Today says that the San Francisco Giants “have keen interest” in Rays third baseman Evan Longoria.
Longoria is coming off his worst season as a major leaguer, having hit .261/.313/.424 with 20 homers in 2017. He’s also still owed $86 million through 2022. Which, back when the deal was signed seemed like quite a bargain for the Rays — and likely has been over the duration of the contract — but now seems somewhat steep for the 32 year-old third baseman. That said, the Giants currently have Pablo Sandoval penciled in at third base on their depth chart, so Longoria would definitely be an upgrade, even if 2017’s dip wasn’t just a blip.
Nightengale says that for the Giants to take on Longoria, the Rays would have to take on a high salary veteran such as Denard Span or Hunter Pence. Span is owed $9 million in 2018, with a $4 million buyout on a $12 million option for 2019. Pence is owed $18.5 million in 2018 in the final year of his contract and has a full no-trade clause.
If he stays with the Rays, Longoria will achieve 10-5 rights — full no-trade protection due to being a ten-year veteran with five years of service on the same club — so if the Rays are going to move him, it’ll be much easier this offseason, not once the 2018 season begins.